2024 annual financial data
Cytek Biosciences 2024 Net income growth
Direct answer
Net income growth was 50.44%.
Operating income was -20,523,000 USD and net income was -6,020,000 USD.
Operating cash flow was 25,379,000 USD.
Get free Cytek Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 200,453,000 USD
- Operating income
- -20,523,000 USD
- Net income
- -6,020,000 USD
- Operating cash flow
- 25,379,000 USD